Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.9800 (-3.06%) ($6.9400 - $7.3500) on Tue. May. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.54% (three month average) | RSI | 34 | Latest Price | $6.9800(-3.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.7% a day on average for past five trading days. | Weekly Trend | TGTX declines -4.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(65%) ARKG(58%) IBB(58%) ARKK(56%) IWO(56%) | Factors Impacting TGTX price | TGTX will decline at least -1.77% in a week (0% probabilities). VXX(-37%) TLT(-9%) VIXM(-6%) UUP(-6%) IFRA(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.77% (StdDev 3.54%) | Hourly BBV | 0 () | Intraday Trend | -3.6% | | | |
|
Resistance Level | $7.41 | 5 Day Moving Average | $7.04(-0.85%) | 10 Day Moving Average | $6.98(0%) | 20 Day Moving Average | $7.41(-5.8%) | To recent high | -17.7% | To recent low | 14.8% | Market Cap | $884m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |